Clinical Trial Update: Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations [NA]

View source ↗

Summary

A University of Bern-led clinical trial is recruiting to evaluate using a polygenic risk score to optimize primary prevention in intermediate-risk individuals a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: University of Bern | Conditions: Primary Prevention of Cardiovascular Disease | NA | Status: RECRUITING